Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300 million aggregate principal amount of its 3.25% convertible senior…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
